PMID- 28945811 OWN - NLM STAT- MEDLINE DCOM- 20171023 LR - 20220310 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 12 IP - 9 DP - 2017 TI - Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease. PG - e0185242 LID - 10.1371/journal.pone.0185242 [doi] LID - e0185242 AB - IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a fatal, rapidly progressive neurodegenerative disease that primarily affects motor neurons. Recently, three causative genes have been implicated in both ALS and glaucoma. However, it is still uncertain whether patients with ALS have neurodegeneration in their retinas. If so, retinal thickness measurements might be a useful biomarker for ALS progression. Previous work in this area has been inconclusive, as it has not taken into account the effect of ophthalmic diseases on retinal thinning. OBJECTIVE: To determine whether there are differences in retinal neurons in ALS patients utilizing spectral-domain optical coherence tomography (SD-OCT). We tested the hypothesis that ALS patients exhibit retinal neurodegeneration that is not associated with ophthalmic diseases. DESIGN, SETTINGS AND PARTICIPANTS: Observational, comparative, cross-sectional study performed on patients recruited from the Duke University Medical Center ALS clinic. Patients underwent a comprehensive ophthalmologic examination to rule out ocular pathology. 21 patients met inclusion criteria. Two eyes with ocular pathology were excluded, leading to a total of 40 eyes of 21 patients included in the study. Retinal neurodegeneration was assessed by retinal nerve fiber layer (RNFL) thickness measurement using SD-OCT (Spectralis; Heidelberg Engineering). MAIN OUTCOMES AND MEASURES: ALS disease severity, determined through the ALS Functional Rating Scale (ALSFRS-R); mean and six sector RNFL thickness values compared to age-adjusted values in the normative database provided by Heidelberg Engineering; RNFL thickness correlation with ALSFRS-R, ALSFRS-R progression rate, forced vital capacity (FVC), and visual acuity. RESULTS: ALSFRS-R mean score was 30+/-10. Mean RNFL thickness in ALS patients was 88.95 +/- 10.8 microns, significantly thinner than values in the normative database (95.81 +/- 0.8). These RNFL thickness values did not demonstrate correlation to ALSFRS-R score, ALSFRS-R progression rate, FVC, intraocular pressure, or visual acuity. CONCLUSIONS: Using SD-OCT, our study shows that ALS patients without ocular pathology exhibit thinned retinal layers. Future studies are warranted to clarify the clinical relationship between retinal thinning and motor neuron loss in ALS. FAU - Mukherjee, Nisha AU - Mukherjee N AD - Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America. FAU - McBurney-Lin, Shan AU - McBurney-Lin S AUID- ORCID: 0000-0001-9829-5748 AD - Duke University School of Medicine, Durham, North Carolina, United States of America. FAU - Kuo, Anthony AU - Kuo A AD - Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America. FAU - Bedlack, Richard AU - Bedlack R AD - Duke ALS Clinic, Duke University Medical Center, Durham, North Carolina, United States of America. FAU - Tseng, Henry AU - Tseng H AD - Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America. LA - eng PT - Journal Article PT - Observational Study DEP - 20170925 PL - United States TA - PLoS One JT - PloS one JID - 101285081 SB - IM MH - Adult MH - Aged MH - Amyotrophic Lateral Sclerosis/genetics/*pathology/physiopathology MH - Cross-Sectional Studies MH - Disease Progression MH - Female MH - Humans MH - Intraocular Pressure MH - Male MH - Middle Aged MH - Nerve Degeneration/pathology MH - Nerve Fibers/pathology MH - Retina/*pathology MH - Retinal Neurons/pathology MH - Tomography, Optical Coherence/methods MH - Visual Acuity PMC - PMC5612691 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2017/09/26 06:00 MHDA- 2017/10/24 06:00 PMCR- 2017/09/25 CRDT- 2017/09/26 06:00 PHST- 2017/03/16 00:00 [received] PHST- 2017/09/09 00:00 [accepted] PHST- 2017/09/26 06:00 [entrez] PHST- 2017/09/26 06:00 [pubmed] PHST- 2017/10/24 06:00 [medline] PHST- 2017/09/25 00:00 [pmc-release] AID - PONE-D-17-10479 [pii] AID - 10.1371/journal.pone.0185242 [doi] PST - epublish SO - PLoS One. 2017 Sep 25;12(9):e0185242. doi: 10.1371/journal.pone.0185242. eCollection 2017.